|
John Hoeven
|
senate |
AbbVie Inc. (NYSE) |
ABBV |
STOCK |
Purchase
|
Feb. 25, 2015 |
$$100,001 - $250,000 |
March 9, 2015 |
|
Thomas R Carper
|
senate |
AbbVie Inc. (NYSE) |
ABBV |
STOCK |
Purchase
|
Feb. 12, 2015 |
$$1,001 - $15,000 |
March 3, 2015 |
|
Adam B. Schiff
|
house |
Abbvie Inc Com |
ABBV |
STOCK |
Purchase
|
Feb. 6, 2015 |
$$1,001 - $15,000 |
Jan. 10, 2018 |
|
James B. Renacci
|
house |
ABBVIE |
ABBV |
STOCK |
PURCHASE
|
Feb. 4, 2015 |
$$1,000 - $15,000 |
Feb. 18, 2015 |
|
James B. Renacci
|
house |
ABBVIE |
ABBV |
STOCK |
PURCHASE
|
Feb. 4, 2015 |
$$1,000 - $15,000 |
Feb. 18, 2015 |
|
James B. Renacci
|
house |
ABBVIE |
ABBV |
STOCK |
PURCHASE
|
Feb. 3, 2015 |
$$1,000 - $15,000 |
Feb. 18, 2015 |
|
Thomas MacArthur
|
house |
Banco Bilbao Vizcaya Argentaria S.A. (BBVA) |
BBVA |
STOCK |
Sale
|
Jan. 27, 2015 |
$$1,001 - $15,000 |
March 5, 2015 |
|
Thomas MacArthur
|
house |
Banco Bilbao Vizcaya Argentaria S.A. (BBVA) |
BBVA |
STOCK |
Purchase
|
Jan. 26, 2015 |
$$15,001 - $50,000 |
March 5, 2015 |
|
Sheldon Whitehouse
|
senate |
AbbVie Inc. (NYSE) |
ABBV |
STOCK |
Purchase
|
Dec. 18, 2014 |
$$1,001 - $15,000 |
Jan. 5, 2015 |
|
Bill Flores
|
house |
abbVie Inc. (aBBV) |
ABBV |
STOCK |
Sale
|
Dec. 16, 2014 |
$$50,001 - $100,000 |
Jan. 12, 2015 |
|
James B. Renacci
|
house |
ABBVIE INCORPORATED (ABBV) |
ABBV |
STOCK |
SALE
|
Dec. 2, 2014 |
$$15,001 - $50,000 |
Dec. 22, 2014 |
|
James B. Renacci
|
house |
ABBVIE INCORPORATED (ABBV) |
ABBV |
STOCK |
PURCHASE
|
Dec. 2, 2014 |
$$15,001 - $50,000 |
Dec. 22, 2014 |
|
Katherine M. Clark
|
house |
abbVie Inc. (abbV) |
ABBV |
STOCK |
Purchase
|
Nov. 13, 2014 |
$$1,001 - $15,000 |
Dec. 19, 2014 |
|
Katherine M. Clark
|
house |
abbVie Inc. (abbV) |
ABBV |
STOCK |
Sale
|
Nov. 13, 2014 |
$$1,001 - $15,000 |
Dec. 19, 2014 |
|
Katherine M. Clark
|
house |
abbVie Inc. (abbV) |
ABBV |
STOCK |
Purchase
|
Oct. 27, 2014 |
$$1,001 - $15,000 |
Dec. 19, 2014 |
|
James B. Renacci
|
house |
ABBVIE, INCORPORATED (ABBV) |
ABBV |
STOCK |
Sale
|
Oct. 16, 2014 |
$$1,000 - $15,000 |
Nov. 10, 2014 |
|
James B. Renacci
|
house |
ABBVIE INCORPORATED (ABBV) |
ABBV |
STOCK |
Sale
|
Oct. 16, 2014 |
$$1,000 - $15,000 |
Nov. 10, 2014 |
|
Katherine M. Clark
|
house |
abbVie Inc. (abbV) |
ABBV |
STOCK |
Sale
|
Oct. 15, 2014 |
$$1,001 - $15,000 |
Dec. 19, 2014 |
|
John Hoeven
|
senate |
AbbVie Inc. (NYSE) |
ABBV |
STOCK |
Sale (Full)
|
Sept. 29, 2014 |
$$100,001 - $250,000 |
Oct. 22, 2014 |
|
James B. Renacci
|
house |
ABBVIE INCORPORATED |
ABBV |
STOCK |
PURCHASE
|
Sept. 15, 2014 |
$$1,000 - $15,000 |
Sept. 22, 2014 |
|
James B. Renacci
|
house |
ABBVIE INCORPORATED (ABBV) |
ABBV |
STOCK |
PURCHASE
|
Sept. 12, 2014 |
$$1,000 - $15,000 |
Sept. 22, 2014 |
|
Tammy Duckworth
|
house |
abbV (AbbVie Inc.) |
ABBV |
STOCK |
S
|
Sept. 5, 2014 |
$$1,001 - $15,000 |
Sept. 23, 2014 |
|
James B. Renacci
|
house |
ABBVIE INCORPORATED (ABBV) |
ABBV |
STOCK |
PURCHASE
|
July 31, 2014 |
$$1,000 - $15,000 |
Aug. 6, 2014 |
|
James B. Renacci
|
house |
ABBVIE INCORPORATED (ABBV) |
ABBV |
STOCK |
PURCHASE
|
July 30, 2014 |
$$15,001 - $50,000 |
Aug. 6, 2014 |
|
John Hoeven
|
senate |
AbbVie Inc. (NYSE) |
ABBV |
STOCK |
Purchase
|
April 28, 2014 |
$$50,001 - $100,000 |
May 8, 2014 |